Selection from HEOR Bibliography
| Search criteria | ||||
| Thailand |
||||
| A cross-sectional survey to evaluate prescribers' knowledge and understanding of safety messages following Dengvaxia® product information update | ||||
| Mariana F Almas 1, Massoud Toussi 2, Elisa Valero 3, Annick Moureau 4, Lydie Marcelon | ||||
| 1IQVIA Real World Solutions, Porto Salvo, Portugal. 2IQVIA Real World &Analytics Solutions, La Défense, France. 3Global Pharmacovigilance, Sanofi Pasteur, Lyon, France. 4Global Biostatistical Sciences, Sanofi Pasteur, Marcy l'Etoile, France. 5Epidemiology and Benefit Risk, Global Pharmacovigilance, Sanofi Pasteur, Lyon, France. | ||||
| Pharmacoepidemiol Drug Saf . 2022 Jul;31(7):758-768. doi: 10.1002/pds.5447. Epub 2022 May 13 |
||||
| , Article | ||||
| , Brazil, Thailand | ||||
| Abstract: https://pubmed.ncbi.nlm.nih.gov/35505623/ | ||||
| Condition | Year | Language | Analysis type | |
| , Immunology and Vaccination, Risk Management & REMS | 2022 | English | , Clinical setting: Primary care, Epidemiological study, Survey research | |
| Utility and Willingness to Pay for Lung Cancer Treatments: Patient Versus General Population Values in Thailand. | ||||
| Thongprasert S, Permsuwan U, Sakulbumrungsil R, Chaiyakunapruk N, Crawford B, Petcharapiruch S1, Leartsakulpanitch J. | ||||
| 1Outcomes Resarch, Medical Department, Pfizer (Thailand) Limited, Thailand | ||||
| HTAi (June 17 – 19, 2013, Seoul Korea). |
||||
| , Poster | ||||
| , Thailand | ||||
| Abstract: http://www.novelhealthstrategies.com/KoreaHTAiSchedule.pdf | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology | 2013 | English | , Economic evaluation | |
| The cost-effectiveness of travoprost preserved with polyquad® in newly treated open-angle glaucoma patients in 7 Asian countries. | ||||
| Gerlier L1, Lamotte M1, Caputo J2, Tan R3 | ||||
| 1 IMS Health Consulting EMEA, Vilvoorde, Belgium 2 IMS Health Consulting Asia-Pacific, Singapore 3 ALCON, Asia-Pacific, Singapore | ||||
| 5th ISPOR Asia-Pacific Conference, 2012, September 2-4, Taipei, Taiwan |
||||
| , Abstract, Poster | ||||
| , India, Malaysia, Singapore, South Korea, Thailand | ||||
| Condition | Year | Language | Analysis type | |
| , Ophthalmology | 2012 | English | , Cost effectiveness | |
| Medical resource use and associated costs in open-angle glaucoma in 10 Asia-pacific countries. | ||||
| Gerlier L1, Lamotte M1, Caputo J2, Tan R3 | ||||
| 1 IMS Health Consulting EMEA, Vilvoorde, Belgium 2 IMS Health Consulting Asia-Pacific, Singapore 3 ALCON, Asia-Pacific, Singapore | ||||
| 5th ISPOR Asia-Pacific Conference, 2012, September 2-4, Taipei, Taiwan |
||||
| , Abstract, Poster | ||||
| , Australia, China, Hong Kong, India, Malaysia, New Zealand, Singapore, South Korea, Taiwan, Thailand | ||||
| Condition | Year | Language | Analysis type | |
| , Ophthalmology | 2012 | English | , Burden of illness | |